S100A7 and osteosarcoma: Knockdown of S100A7 suppresses lung cancer growth in part by attenuating NF-κB activity, and S100A7 promotes the migration and invasion of osteosarcoma cells and enhances the activity of MMP2 and MMP9 through RAGE [10, 19].